Risk factors associated with hypoglycemic events after total pancreatectomy: A nationwide multicenter prospective study in Japan



      The number of total pancreatectomy cases have increased worldwide, expanding the need for new insulin products and high-titer pancrelipases. However, the current data that is focused on hypoglycemic events after a total pancreatectomy from large nationwide series are still lacking. This study is aimed to assess the risk factors associated with hypoglycemic events after a total pancreatectomy.


      Data were prospectively collected from 216 consecutive patients who underwent total pancreatectomies between August 2015 and December 2017 from 68 Japanese centers. Of the 216 patients, 166 with a follow-up period of 1 year were analyzed. The risk factors for hypoglycemic events at 6 and 12 months (postoperative months 6 and 12) were investigated based on the results of a nationwide multicenter prospective study.


      Of the 166 patients, 57 (34%) and 70 (42%) experienced moderate or severe hypoglycemic events or hypoglycemia unawareness on a monthly basis at postoperative months 6 and 12, respectively. Multivariate analysis revealed that body weight loss after surgery ≥0.3 kg and total cholesterol level ≤136 mg/dL at postoperative month 6, and glycated hemoglobin level ≤8.9% and rapid-acting insulin use at postoperative month 12 were independent risk factors for hypoglycemic events after a total pancreatectomy. There were different independent risk factors depending on the postoperative period.


      Patients with body weight loss after surgery, low total cholesterol level, strict glycemic control, and using rapid-acting insulin should be aware of the occurrence of hypoglycemic events after their total pancreatectomy. In order to prevent hypoglycemic events after a total pancreatectomy, we need to consider optimal nutritional and glycemic control according to the postoperative period.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Scavini M.
        • Dugnani E.
        • Pasquale V.
        • et al.
        Diabetes after pancreatic surgery: novel issues.
        Curr Diab Rep. 2015; 15: 16
        • Kiviluoto T.
        • Schroder T.
        • Karonen S.L.
        • Kuusi T.
        • Lempinen M.
        • Taskinen M.R.
        Glycemic control and serum lipoproteins after total pancreatectomy.
        Ann Clin Res. 1985; 17: 110-115
        • Dresler C.M.
        • Fortner J.G.
        • McDermott K.
        • Bajorunas D.R.
        Metabolic consequences of (regional) total pancreatectomy.
        Ann Surg. 1991; 214: 131-140
        • Duron F.
        • Duron J.J.
        Pancreatectomy and diabetes [article in French].
        Ann Chir. 1999; 53: 406-411
        • Sauvanet A.
        Functional results of pancreatic surgery [article in French].
        Rev Prat. 2002; 52: 1572-1575
        • Jethwa P.
        • Sodergren M.
        • Lala A.
        • et al.
        Diabetic control after total pancreatectomy.
        Dig Liver Dis. 2006; 38: 415-419
        • Datta J.
        • Lewis Jr., R.S.
        • Strasberg S.M.
        • et al.
        Quantifying the burden of complications following total pancreatectomy using the postoperative morbidity index: a multi-institutional perspective.
        J Gastrointest Surg. 2015; 19: 506-515
        • Roberts K.J.
        • Blanco G.
        • Webber J.
        • et al.
        How severe is diabetes after total pancreatectomy? A case-matched analysis.
        HPB (Oxford). 2014; 16: 814-821
        • Hartwig W.
        • Gluth A.
        • Hinz U.
        • et al.
        Total pancreatectomy for primary pancreatic neoplasms: renaissance of an unpopular operation.
        Ann Surg. 2015; 261: 537-546
        • Kakeji Y.
        • Takahashi A.
        • Udagawa H.
        • et al.
        Surgical outcomes in gastroenterological surgery in Japan: report of National Clinical database 2011-2016.
        Ann Gastroenterol Surg. 2018; 2: 37-54
        • Suto H.
        • Kamei K.
        • Kato H.
        • et al.
        Diabetic control and nutritional status up to 1 year after total pancreatectomy: a nationwide multicentre prospective study.
        Br J Surg. 2021; : 1-2
        • Kato H.
        • Kamei K.
        • Suto H.
        • et al.
        Incidence and risk factors of nonalcoholic fatty liver disease after total pancreatectomy: a first multicenter prospective study in Japan.
        J Hepatobilialy Pancreat Sci. 2022; 29: 428-438
      1. Frier B.M. Heller S. McCrimmon R. Hypoglycaemia in Clinical Diabetes. 3rd ed. Wiley-Blackwell, Chichester, UK2014
        • Pulvirenti A.
        • Pea A.
        • Rezaee N.
        • et al.
        Perioperative outcomes and long-term quality of life after total pancreatectomy.
        Br J Surg. 2019; 106: 1819-1828
        • Scholten L.
        • Latenstein A.E.J.
        • van Eijck C.
        • et al.
        Outcome and long-term quality of life after total pancreatectomy (PANORAMA): a nationwide cohort study.
        Surgery. 2019; 166: 1017-1026
        • Watanabe Y.
        • Ohtsuka T.
        • Matsunaga T.
        • et al.
        Long-term outcomes after total pancreatectomy: special reference to survivors' living conditions and quality of life.
        World J Surg. 2015; 39: 1231-1239
        • Epelboym I.
        • Winner M.
        • DiNorcia J.
        • et al.
        Quality of life in patients after total pancreatectomy is comparable with quality of life in patients who undergo a partial pancreatic resection.
        J Surg Res. 2014; 187: 189-196
        • Crippa S.
        • Tamburrino D.
        • Partelli S.
        • et al.
        Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes.
        Surgery. 2011; 149: 79-86
        • Kiran R.P.
        • Turina M.
        • Hammel J.
        • Fazio V.
        The clinical significance of an elevated postoperative glucose value in nondiabetic patients after colorectal surgery: evidence for the need for tight glucose control?.
        Ann Surg. 2013; 258 (discussion 604–605): 599-604
        • Ambiru S.
        • Kato A.
        • Kimura F.
        • et al.
        Poor postoperative blood glucose control increases surgical site infections after surgery for hepato-biliary-pancreatic cancer: a prospective study in a high-volume institute in Japan.
        J Hosp Infect. 2008; 68: 230-233
        • Cheon Y.K.
        • Koo J.K.
        • Lee Y.S.
        • Lee T.Y.
        • Shim C.S.
        Elevated hemoglobin A1c levels are associated with worse survival in advanced pancreatic cancer patients with diabetes.
        Gut Liver. 2014; 8: 205-214
        • Fan K.Y.
        • Dholakia A.S.
        • Wild A.T.
        • et al.
        Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancer.
        J Natl Compr Canc Netw. 2014; 12: 50-57
        • Shi H.J.
        • Jin C.
        • Fu D.L.
        Impact of postoperative glycemic control and nutritional status on clinical outcomes after total pancreatectomy.
        World J Gastroenterol. 2017; 23: 265-274
        • Belyaev O.
        • Herzog T.
        • Chromik A.M.
        • Meurer K.
        • Uhl W.
        Early and late postoperative changes in the quality of life after pancreatic surgery.
        Langenbecks Arch Surg. 2013; 398: 547-555
        • Billings B.J.
        • Christein J.D.
        • Harmsen W.S.
        • et al.
        Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up?.
        J Gastrointest Surg. 2005; 9 (discussion 66–67): 1059-1066
        • Muller M.W.
        • Friess H.
        • Kleeff J.
        • et al.
        Is there still a role for total pancreatectomy?.
        Ann Surg. 2007; 246 (discussion 74–75): 966-974
        • Struyvenberg M.R.
        • Fong Z.V.
        • Martin C.R.
        • et al.
        Impact of treatments on diabetic control and gastrointestinal symptoms after total pancreatectomy.
        Pancreas. 2017; 46: 1188-1195
        • Karagianni P.
        • Sampanis C.
        • Katsoulis C.
        • et al.
        Continuous subcutaneous insulin infusion versus multiple daily injections.
        Hippokratia. 2009; 13: 93-96
        • Hanaire-Broutin H.
        • Melki V.
        • Bessieres-Lacombe S.
        • Tauber J.P.
        Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
        Diabetes Care. 2000; 23: 1232-1235
        • DeVries J.H.
        • Snoek F.J.
        • Kostense P.J.
        • Masurel N.
        • Heine R.J.
        Dutch Insulin Pump Study G. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.
        Diabetes Care. 2002; 25: 2074-2080
        • Tricco A.C.
        • Ashoor H.M.
        • Antony J.
        • et al.
        Comparative efficacy and safety of ultra-long-acting, long-acting, intermediate-acting, and biosimilar insulins for type 1 diabetes mellitus: a systematic review and network meta-analysis.
        J Gen Intern Med. 2021; 36: 2414-2426
        • Levin P.
        • Hoogwerf B.J.
        • Snell-Bergeon J.
        • Vigers T.
        • Pyle L.
        • Bromberger L.
        Ultra rapid-acting inhaled insulin improves glucose control in patients with type 2 diabetes mellitus.
        Endocr Pract. 2021; 27: 449-454
        • Geng Y.
        • Qi Q.
        • Sun M.
        • Chen H.
        • Wang P.
        • Chen Z.
        Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer. Eur.
        J Surg Oncol. 2015; 41: 1508-1514
        • Vashi P.
        • Popiel B.
        • Lammersfeld C.
        • Gupta D.
        Outcomes of systematic nutritional assessment and medical nutrition therapy in pancreatic cancer.
        Pancreas. 2015; 44: 750-755
        • Sutherland D.E.
        • Radosevich D.M.
        • Bellin M.D.
        • et al.
        Total pancreatectomy and islet autotransplantation for chronic pancreatitis.
        J Am Coll Surg. 2012; 214: 409-424
        • Chinnakotla S.
        • Beilman G.J.
        • Dunn T.B.
        • et al.
        Factors predicting outcomes after a total pancreatectomy and islet autotransplantation lessons learned from over 500 cases.
        Ann Surg. 2015; 262: 610-622
        • Young M.C.
        • Theis J.R.
        • Hodges J.S.
        • et al.
        Preoperative computerized tomography and magnetic resonance imaging of the pancreas predicts pancreatic mass and functional outcomes after total pancreatectomy and islet autotransplant.
        Pancreas. 2016; 45: 961-966
        • Quartuccio M.
        • Hall E.
        • Singh V.
        • et al.
        Glycemic predictors of insulin independence after total pancreatectomy with islet autotransplantation.
        J Clin Endocrinol Metab. 2017; 102: 801-809
        • Wilson G.C.
        • Sutton J.M.
        • Abbott D.E.
        • et al.
        Long-term outcomes after total pancreatectomy and islet cell autotransplantation: is it a durable operation?.
        Ann Surg. 2014; 260: 659-665
        • Ahmad S.A.
        • Lowy A.M.
        • Wray C.J.
        • et al.
        Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis.
        J Am Coll Surg. 2005; 201: 680-687
        • Bramis K.
        • Gordon-Weeks A.N.
        • Friend P.J.
        • et al.
        Systematic review of total pancreatectomy and islet autotransplantation for chronic pancreatitis.
        Br J Surg. 2012; 99: 761-766
        • Tamborlane W.V.
        • Beck R.W.
        • Bode B.W.
        • et al.
        Continuous glucose monitoring and intensive treatment of type 1 diabetes.
        N Engl J Med. 2008; 359: 1464-1476
        • Julia F.
        • Roman H.
        Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy.
        Expert Rev Med Devices. 2020; 17: 707-720